Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 28 results.
User Information
Export Records
  1. 1.   Targeting chemoresistance in Xp11.2 translocation renal cell carcinoma using a novel polyamide-chlorambucil conjugate
  2. Funasaki, Shintaro; Mehanna, Sally; Ma, Wenjuan; Nishizawa, Hidekazu; Kamikubo, Yasuhiko; Sugiyama, Hiroshi; Ikeda, Shuji; Motoshima, Takanobu; Hasumi, Hisashi; Linehan, W Marston; Schmidt,Laura; Ricketts, Chris; Suda, Toshio; Oike, Yuichi; Kamba, Tomomi; Baba, Masaya
  3. Cancer Science. 2022, Apr 09;
  1. 2.   Clarification of the Mechanism of Acylation Reaction and Origin of Substrate Specificity of the Serine-Carboxyl Peptidase Sedolisin through QM/MM Free Energy Simulations
  2. Xu, Q.; Yao, J. Z.; Wlodawer, A.; Guo, H.
  3. Journal of Physical Chemistry B. 2011, Mar; 115(10): 2470-2476.
  1. 3.   Novel Peptides Based on HIV-1 gp120 Sequence with Homology to Chemokines Inhibit HIV Infection in Cell Culture
  2. Chertov, O.; Zhang, N.; Chen, X.; Oppenheim, J. J.; Lubkowski, J.; McGrath, C.; Sowder, R. C.; Crise, B. J.; Malyguine, A.; Kutzler, M. A.; Steele, A. D.; Henderson, E. E.; Rogers, T. J.
  3. Plos One. 2011, Jan 11; 6(1): 10.
  1. 4.   Current Status of Thalidomide and CC-5013 in the Treatment of Metastatic Prostate Cancer
  2. Sissung, T. M.; Thordardottir, S.; Gardner, E. R.; Figg, W. D.
  3. Anti-cancer agents in medicinal chemistry. 2009 9(10): 1058-1069.
  1. 5.   Loss of PL6 protein expression in renal clear cell carcinomas and other VHL-deficient tumours
  2. Ivanova, A. V.; Vortmeyer, A.; Ivanov, S. V.; Nickerson, M. L.; Maher, E. R.; Lerman, M. I.
  3. Journal of Pathology. 2008 214(1): 46-57.
  1. 6.   Thalidomide analogues as anticancer drugs
  2. Aragon-Ching, J. B.; Li, H. Q.; Gardner, E. R.; Figg, W. D.
  3. Recent Patents on Anti-Cancer Drug Discovery. 2007, Jun; 2(2): 167-174.
  1. 7.   Noninfectious papilloma virus-like particles inhibit HIV-1 replication: implications for immune control of HIV-1 infection by IL-27
  2. Fakruddin, J. M.; Lempicki, R. A.; Gorelick, R. J.; Yang, J.; Adelsberger, J. W.; Garcia-Pineres, A. J.; Pinto, L. A.; Lanes, H. C.; Imamichi, T.
  3. Blood. 2007, Mar; 109(5): 1841-1849.
  1. 8.   The QM/MM molecular dynamics and free energy simulations of the acylation reaction catalyzed by the serine-carboxyl peptidase kumamolisin-As
  2. Xu, Q.; Guo, H. B.; Wlodawer, A.; Nakayama, T.; Guo, H.
  3. Biochemistry. 2007, Mar; 46(12): 3784-3792.
  1. 9.   Innate immune dysfunction in HIV infection: Effect of HIV envelope-NK cell interactions
  2. Kottilil, S.; Shin, K.; Jackson, J. O.; Reitano, K. N.; O'Shea, M. A.; Yang, J.; Hallahan, C. W.; Lempicki, R.; Arthos, J.; Fauci, A. S.
  3. Journal of Immunology. 2006, JAN 15; 176(2): 1107-1114.
  1. 10.   Autoantigens act as tissue-specific chemoattractants
  2. Oppenheim, J. J.; Dong, H. F.; Plotz, P.; Caspi, R. R.; Dykstra, M.; Pierce, S.; Martin, R.; Carlos, C.; Finn, O.; Koul, O.; Howard, O. M. Z.
  3. Journal of Leukocyte Biology. 2005, JUN; 77(6): 854-861.
  1. 11.   Recombinant guinea pig CCL5 (RANTES) differentially modulates cytokine production in alveolar and peritoneal macrophages
  2. Skwor, T. A.; Cho, H. S.; Cassidy, C.; Yoshimura, T.; McMurray, D. N.
  3. Journal of Leukocyte Biology. 2004, DEC; 76(6): 1229-1239.
  1. 12.   CCL3L1 and CCL4L1 chemokine genes are located in a segmental duplication at chromosome 17ql2
  2. Modi, W. S.
  3. Genomics. 2004 83(4): 735-738.
  1. 13.   Up-regulated expression and activation of the. orphan chemokine receptor, CCRL2, in rheumatoid arthritis
  2. Galligan, C. L.; Matsuyama, W.; Matsukawa, A.; Mizuta, H.; Hodge, D. R.; Howard, O. M. Z.; Yoshimura, T.
  3. Arthritis and Rheumatism. 2004 50(6): 1806-1814.
  1. 14.   An expanding appreciation of the role chemokine receptors play in cancer progression
  2. Howard, O. M. Z.; Galligan, C. L.
  3. Current Pharmaceutical Design. 2004 10(19): 2377-2389.
  1. 15.   Phenotypic and functional changes of cytokine-activated neutrophils
  2. Galligan, C.; Yoshimura, T.
  3. Neutrophil: An Emerging Regulator of Inflammatory and Immune Response. 2003; 83 : 24-44.
  1. 16.   Crystallization and preliminary X-ray studies of thymus and activation-regulated chemokine (TARC)
  2. Asojo, O. A.; Cater, S.; Hoover, D. M.; Boulegue, C.; Lu, W. Y.; Lubkowski, J.
  3. Acta Crystallographica Section D-Biological Crystallography. 2003 59(Part 1): 163-165.
  1. 17.   MCP-1-MCP-3-eotaxin gene cluster influences HIV-1 transmission
  2. Modi, W. S.; Goedert, J. J.; Strathdee, S.; Buchbinder, S.; Detels, R.; Donfield, S.; O'Brien, S. J.; Winkler, C.
  3. Aids. 2003 17(16): 2357-2365.
  1. 18.   Structures of thymus and activation-regulated chemokine (TARC)
  2. Asojo, O. A.; Boulegue, C.; Hoover, D. M.; Lu, W. Y.; Lubkowski, J.
  3. Acta Crystallographica Section D-Biological Crystallography. 2003 59(Part 7): 1165-1173.
  1. 19.   DNAWorks: an automated method for designing oligonucleotides for PCR-based gene synthesis
  2. Hoover, D. M.; Lubkowski, J.
  3. Nucleic Acids Research. 2002 30(10): art. no.-e43.
  1. 20.   Manipulating chemoattractant and receptor genes
  2. Le, Y. Y.; Cui, Y. H.; Iribarren, P.; Ying, G. G.; Wang, J. M.
  3. In Vivo. 2002 16(1): 1-23.
  1. 21.   Balanced polymorphism selected by genetic versus infectious human disease
  2. Dean, M.; Carrington, M.; O'Brien, S. J.
  3. Annual review of genomics and human genetics. 2002 3: 263-292.
  1. 22.   Crystal structure of paprika ferredoxin-NADP(+) reductase - Implications for the electron transfer pathway
  2. Dorowski, A.; Hofmann, A.; Steegborn, C.; Boicu, M.; Huber, R.
  3. Journal of Biological Chemistry. 2001 276(12): 9253-9263.
  1. 23.   Considering genetic profiles in functional studies of immune responsiveness to HIV-1
  2. Carrington, M.; Nelson, G.; O'Brien, S. J.
  3. Immunology Letters. 2001 79(1-2): 131-140.
  1. 24.   Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy
  2. O'Brien, T. R.; McDermott, D. H.; Ioannidis, J. P. A.; Carrington, M.; Murphy, P. M.; Havlir, D. V.; Richman, D. D.
  3. Aids. 2000 14(7): 821-826.
  1. 25.   Total chemical synthesis and high-resolution crystal structure of the potent anti-HIV protein AOP-RANTES
  2. Wilken, J.; Hoover, D.; Thompson, D. A.; Barlow, P. N.; McSparron, H.; Picard, L.; Wlodawer, A.; Lubkowski, J.; Kent, S. B. H.
  3. Chemistry & Biology. 1999 6(1): 43-51.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel